AstraZeneca eyes potential merger with Gilead Sciences

AstraZeneca, valued at $140 billion, is the U.K.’s biggest drugmaker by market capitalization and has developed treatments for conditions from cancer to cardiovascular disease.

from Hindustan Times - business https://ift.tt/2BM3Dq5